Peter A. Thompson, Director at Janux Therapeutics, Inc. (JANX), sold 393,300 shares at $19.07 ($7.5M) on 2021-12-16, disclosed to the SEC on 2021-12-17.
Open-market sale of $7.5M JANX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.07 | 36,500 | $696K | 9.3% |
| 2 | $19.07 | 356,800 | $6.8M | 90.7% |
| Total | $19.07 avg | 393,300 | $7.5M | 100% |
| Filing → |
| SION | SELL | 2026-05-29 | $4K | — | Filing → |
| SION | SELL | 2026-05-11 | $13.4M | — | Filing → |
| SION | SELL | 2026-04-21 | $2.5M | — | Filing → |